Inhaled corticosteroids in stable COPD patients: do they have effects on cells and molecular mediators of airway inflammation?

Balbi, B; Majori, M; Bertacco, S; Convertino, G; Cuomo, A; Donner, C F; Pesci, A

Balbi, B; Majori, M; Bertacco, S; Convertino, G; Cuomo, A; Donner, C F; Pesci, A.

Affiliation

Balbi B; Salvatore Maugeri Foundation, Scientific Institute for Care and Research, Sesia, Italy. dirsan.veruno@fsm.it

Chest ; 117(6): 1633-7, 2000 Jun.

Article in En | MEDLINE | ID: mdl-10858395

Subject(s)

Anti-Inflammatory Agents/administration & dosage; Beclomethasone/administration & dosage; Bronchoalveolar Lavage Fluid/immunology; Inflammation Mediators/metabolism; Leukocyte Count/drug effects; Lung Diseases, Obstructive/drug therapy; Administration, Inhalation; Administration, Topical; Aged; Anti-Inflammatory Agents/adverse effects; Beclomethasone/adverse effects; Female; Forced Expiratory Volume/drug effects; Glucocorticoids; Humans; Lung Diseases, Obstructive/immunology; Male; Middle Aged; Neutrophils/drug effects; Prospective Studies

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Beclomethasone / Bronchoalveolar Lavage Fluid / Inflammation Mediators / Leukocyte Count / Lung Diseases, Obstructive / Anti-Inflammatory Agents Type of study: Observational_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Chest Year: 2000 Document type: Article

Search on Google

XML

PubMed Links